MENTOR ACCU-DX

Serial Number 75366965
606

Registration Progress

Application Filed
Oct 2, 1997
Under Examination
Mar 21, 2000
Approved for Publication
Nov 26, 1999
Published for Opposition
Dec 28, 1999
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: MENTOR ACCU-DX
Previous Owner: MENTOR CORPORATION
Classes: 005

Trademark Image

MENTOR ACCU-DX

Basic Information

Serial Number
75366965
Filing Date
October 2, 1997
Published for Opposition
December 28, 1999
Abandonment Date
March 22, 2001
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 22, 2001
Classes
005

Rights Holder

MENTOR CORPORATION

03
Address
5425 Hollister Avenue
Santa Barbara, CA 93111

Ownership History

MENTOR CORPORATION

Original Applicant
03
Santa Barbara, CA

MENTOR CORPORATION

Owner at Publication
03
Santa Barbara, CA

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

12 events
Date Code Type Description Documents
Jun 12, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 27, 2000 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 24, 2000 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 21, 2000 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 28, 1999 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 26, 1999 NPUB O NOTICE OF PUBLICATION Loading...
Oct 8, 1999 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 9, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 25, 1999 CNFR O FINAL REFUSAL MAILED Loading...
Nov 12, 1998 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 19, 1998 CNRT F NON-FINAL ACTION MAILED Loading...
May 18, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
rapid one-step gold dye particle lateral flow immunoassay for in vitro qualitative measurement of fibrinogen and fibrin\fibrinogen degradation products (FDP) in human urine to be used with standard cystoscopic examination to aid in the management of patients with a history of bladder cancer; Point of care rapid immunoassays to screen for prostate cancer and for cervical cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005